SPC-16

N/A

Report date: 2024/11/06 10:06:14

Base Information

Drug NameSPC-16
Drug Alias NameSPC-16 PeptideSPC-16SPU-16
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCentral Nervous System DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSilo Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSilo Pharma Inc
Inactive CompaniesN/A
Active IndicationsCentral Nervous System DiseasesMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A